# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-26-016834
Filing Date
2026-04-27
Accepted
2026-04-27 07:08:41
Documents
44
Period of Report
2026-04-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ef20071554_8k.htm iXBRL | 8-K | 26269
2 | EXHIBIT 99.1 | ef20071554_ex99-1.htm | EX-99.1 | 70342
6 |  | ef20071554_ex99-1slide1.jpg | GRAPHIC | 77918
7 |  | ef20071554_ex99-1slide2.jpg | GRAPHIC | 442494
8 |  | ef20071554_ex99-1slide3.jpg | GRAPHIC | 149493
9 |  | ef20071554_ex99-1slide4.jpg | GRAPHIC | 485165
10 |  | ef20071554_ex99-1slide5.jpg | GRAPHIC | 150876
11 |  | ef20071554_ex99-1slide6.jpg | GRAPHIC | 176261
12 |  | ef20071554_ex99-1slide7.jpg | GRAPHIC | 140882
13 |  | ef20071554_ex99-1slide8.jpg | GRAPHIC | 176275
14 |  | ef20071554_ex99-1slide9.jpg | GRAPHIC | 178147
15 |  | ef20071554_ex99-1slide10.jpg | GRAPHIC | 151593
16 |  | ef20071554_ex99-1slide11.jpg | GRAPHIC | 98075
17 |  | ef20071554_ex99-1slide12.jpg | GRAPHIC | 74628
18 |  | ef20071554_ex99-1slide13.jpg | GRAPHIC | 142265
19 |  | ef20071554_ex99-1slide14.jpg | GRAPHIC | 172225
20 |  | ef20071554_ex99-1slide15.jpg | GRAPHIC | 116354
21 |  | ef20071554_ex99-1slide16.jpg | GRAPHIC | 90458
22 |  | ef20071554_ex99-1slide17.jpg | GRAPHIC | 80838
23 |  | ef20071554_ex99-1slide18.jpg | GRAPHIC | 103178
24 |  | ef20071554_ex99-1slide19.jpg | GRAPHIC | 147946
25 |  | ef20071554_ex99-1slide20.jpg | GRAPHIC | 156890
26 |  | ef20071554_ex99-1slide21.jpg | GRAPHIC | 142711
27 |  | ef20071554_ex99-1slide22.jpg | GRAPHIC | 98059
28 |  | ef20071554_ex99-1slide23.jpg | GRAPHIC | 74594
29 |  | ef20071554_ex99-1slide24.jpg | GRAPHIC | 184683
30 |  | ef20071554_ex99-1slide25.jpg | GRAPHIC | 235879
31 |  | ef20071554_ex99-1slide26.jpg | GRAPHIC | 158821
32 |  | ef20071554_ex99-1slide27.jpg | GRAPHIC | 132149
33 |  | ef20071554_ex99-1slide28.jpg | GRAPHIC | 146380
34 |  | ef20071554_ex99-1slide29.jpg | GRAPHIC | 172916
35 |  | ef20071554_ex99-1slide30.jpg | GRAPHIC | 79253
36 |  | ef20071554_ex99-1slide31.jpg | GRAPHIC | 189559
37 |  | ef20071554_ex99-1slide32.jpg | GRAPHIC | 205056
| Complete submission text file | 0001140361-26-016834.txt |  | 7315474

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | grce-20260427.xsd | EX-101.SCH | 3859
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | grce-20260427_lab.xml | EX-101.LAB | 21966
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | grce-20260427_pre.xml | EX-101.PRE | 16040
47 | EXTRACTED XBRL INSTANCE DOCUMENT | ef20071554_8k_htm.xml | XML | 4232

Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Grace Therapeutics, Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35776 | Film No.: 26896479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)